Literature DB >> 25755539

Preclinical Liver Bud Engineering towards Clinical Target for Liver Diseases.

Shibashish Giri1, Augustinus Bader1.   

Abstract

Entities:  

Keywords:  FDA, food and drug administration; G-CSF, granulocyte-colony stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; MDR, multidrug-resistant; VEGF, vascular endothelial growth factor; XDR, extensively drug-resistant; iPSC, induced pluripotent stem cells

Year:  2014        PMID： 25755539      PMCID： PMC4188855          DOI： 10.1016/j.jceh.2014.02.151

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  15 in total

1.  Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.

Authors:  Pingping Hou; Yanqin Li; Xu Zhang; Chun Liu; Jingyang Guan; Honggang Li; Ting Zhao; Junqing Ye; Weifeng Yang; Kang Liu; Jian Ge; Jun Xu; Qiang Zhang; Yang Zhao; Hongkui Deng
Journal:  Science       Date:  2013-07-18       Impact factor: 47.728

Review 2.  Organogenesis and development of the liver.

Authors:  Karim Si-Tayeb; Frédéric P Lemaigre; Stephen A Duncan
Journal:  Dev Cell       Date:  2010-02-16       Impact factor: 12.270

3.  Vascularized and functional human liver from an iPSC-derived organ bud transplant.

Authors:  Takanori Takebe; Keisuke Sekine; Masahiro Enomura; Hiroyuki Koike; Masaki Kimura; Takunori Ogaeri; Ran-Ran Zhang; Yasuharu Ueno; Yun-Wen Zheng; Naoto Koike; Shinsuke Aoyama; Yasuhisa Adachi; Hideki Taniguchi
Journal:  Nature       Date:  2013-07-03       Impact factor: 49.962

4.  Cytokine regulation of GM-CSF and G-CSF secretion by human umbilical cord vein endothelial cells (HUVEC).

Authors:  S Lenhoff; T Olofsson
Journal:  Cytokine       Date:  1996-09       Impact factor: 3.861

Review 5.  Epigenetic reprogramming in cancer.

Authors:  Mario L Suvà; Nicolo Riggi; Bradley E Bernstein
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

6.  Relationship between vascular development and vascular differentiation during liver organogenesis in humans.

Authors:  Géraldine Gouysse; Anne Couvelard; Sophie Frachon; Raymonde Bouvier; Mimoun Nejjari; Marie Christine Dauge; Gérard Feldmann; Dominique Hénin; Jean Yves Scoazec
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

Review 7.  Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies.

Authors:  Andrew S Lee; Chad Tang; Mahendra S Rao; Irving L Weissman; Joseph C Wu
Journal:  Nat Med       Date:  2013-08-06       Impact factor: 53.440

8.  The first tissue-engineered airway transplantation: 5-year follow-up results.

Authors:  Alessandro Gonfiotti; Massimo O Jaus; Daniel Barale; Silvia Baiguera; Camilla Comin; Federico Lavorini; Giovanni Fontana; Oriol Sibila; Giovanni Rombolà; Philipp Jungebluth; Paolo Macchiarini
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

9.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.

Authors:  Kosuke Yusa; S Tamir Rashid; Helene Strick-Marchand; Ignacio Varela; Pei-Qi Liu; David E Paschon; Elena Miranda; Adriana Ordóñez; Nicholas R F Hannan; Foad J Rouhani; Sylvie Darche; Graeme Alexander; Stefan J Marciniak; Noemi Fusaki; Mamoru Hasegawa; Michael C Holmes; James P Di Santo; David A Lomas; Allan Bradley; Ludovic Vallier
Journal:  Nature       Date:  2011-10-12       Impact factor: 49.962

10.  Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study.

Authors:  Martin J Elliott; Paolo De Coppi; Simone Speggiorin; Derek Roebuck; Colin R Butler; Edward Samuel; Claire Crowley; Clare McLaren; Anja Fierens; David Vondrys; Lesley Cochrane; Christopher Jephson; Samuel Janes; Nicholas J Beaumont; Tristan Cogan; Augustinus Bader; Alexander M Seifalian; J Justin Hsuan; Mark W Lowdell; Martin A Birchall
Journal:  Lancet       Date:  2012-07-26       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.